1) Whiteman VE, Homdo CJ, Reece EA. Management of hypoglycemia and diabetic ketoacidosis in pregnancy. Obst Gynecol Clin No America 1996;23(1):87-107.
2) Mahoney CA. Extreme gestational starvation ketoacidosis: Case report and review of pathophysiology. Am J Kidney Dis 1992;XX(3):276-80.
3) Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16.
4) Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999;48:1807-14.
5) Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 21:B19-26, 1998.
6) Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes. Clinical Obstet Gynecol 43:87-98, 2000.
7) Aldoretta PW, Hay WW. Metabolic substrates for fetal energy metabolism and growth. Clin Perinatol 1995;22(1):15-35.
8) Hay Jr WW. Placental supply of energy and protein substrates to the fetus. Acta Pediatr Suppl 1994;405:13-19.
9) Hagay ZJ. Dibetic Ketoacidosis in pregnancy: Etiology, pathophysiology, and management. Clinical Obstet Gynecol 1994;37(1):39-49.
10) Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin No Amer 1999;26(3):481-87.
11) Illsley NP. Placental glucose transport in diabetic pregnancy. Clinical Obstet Gynecol 2000;43(1):116-26.
12) Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Diabetes 1993;42:1773-85.
13) Okuno S, Akazawa S, Yasuhi I et al. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm metabol res 1995;27:231-34.
14) Barbour LA, Shao J, Qiao L et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynceol 2002;186:512-7.
15) Evain-Brion D, Alsat E, Igout A, Frankenne F, Hennen G. Placental growth hormone variant: assay and clinical aspects. Acta Paediatr Suppl 1994;399:49-51.
16) Alsat E, Guibourdenche J, Couturier A, Evain-Brion D. Physiological role of human placental growth hormone. Molec Cell Endocrinol 1998;140:121-27.
17) Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Ped Endocrinol Metab 2000;13:343-56.
18) McIntyre HD, Serek R, Crane DI, et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab 2000;85:1143-50.
19) Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002 Jul;51(7):2207-13.
20) Brelje TC, Scharp DW, Lacy PE et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 1993;132:879-87.
21) Anthony RV, Limesand SW, Fanning MD, Liang R. Placental lactogen and growth hormone. In Bazer FW, editor, endocrinology of pregnancy. Totowa, New Jersey: Humana Press;1998. p.461-90.
22) Javanovic L, Knopp RH, Brown Z, Conley MR, Park E et al. Declining insulin requirement in the first trimester of diabetic pregnancy. Diabetes Care 2001;24(7):1130-6.
23) Barbour LA, Reusch JE-B. Diabetes in Pregnancy. In McDermott M (ed):, Endocrine Secrets, 3rd ed, Philadelphia, Hanley & Belfus, 2001,308-16.
24) Montoro MN, Myers VP, Mestman JH, et al. Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol 1993;10(1)17-20.
25) DeViciana M, Major CA, Morgan MA, Asrat T, Toohey JS, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237-1241, 1995.
26) Ter Braak EW, Evers IM, Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes/Metab Res Rev 2002:18(2):96-105.
27) American Diabetes Association. Preconception care of women with diabetes, Diabetes Care 23:S65-68, 2000.
28) Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner R. Preconception care of diabetes, medical malformations, and spontaneous abortions. Diabetes Care 1996;19:514-41.
29) Casele HL, Laifer SA. Factors influencing preconception control of glycemia in diabetic women. Arch Intern Med 1998;158:1321-24.
30) Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998:21(6):889-95.
31) Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clicical Obstet Gynecol 2000;43(1):32-45.
32) Garner P. Type I diabetes and pregnancy. Lancet 346:157-161, 1995.
33) Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
34) Homko CJ, Reece EA. Ambulatory care of the pregnant woman with diabetes. Clinical Obstet Gynecol 1998;41(3):584-96.
35) Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah POD et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. Br Med J 1997;315:275-78.
36) Hadden DR, McCance DR. Advances in management of Type 1 diabetes and pregnancy. Current Opinion Obstet Gynecol 1999;11(6):557-62.
37) Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstetric Gynecol 1997;177:1165-71.
38) Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the diabetes control and compliations trial. Am J Obstet Gynecol 1996;174:1343-53.
39) Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetic Med 2000;17(7):507-11.
40) Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith. Metformin throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-5.
41) Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clinical Endo Metab 2002;89(2):524-9.
42) Briggs GC, Freeman RK, Yaffee SJ. Drugs in pregnancy and lactation, 6th edition. Baltimore: Williams and Wilkins 2001.
43) Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 343:1134-8, 2000.
44) Pryde PG, Sedman AB, Nugent CE, Barr M. Angiotensin-converting enzyme fetopathy. J Am Soc Nephol 1993;3:1575-82.
45) National High Blood Pressure Education Program. National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1691-712.
46) Barbour LA, Laiffer SA. Preconception counseling. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000:1-18.
47) Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002;45(1):36-41.
48) Kimmerle R, ZaB RP, Cupisti S, Somville T, Bender R, Pawlowski B, Berger M. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995;38:227-35.
49) Sabai BM, Caritis S,Hauth J, Lindheimer M, Van Dorsten JP. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes melllitus. Am J Obstet Gynecol 2000;182:364-9.
50) Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabetic Med 2001;18(7):573-7.
51) Verge CF, Gianna R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA Chase HP, Eisenbarth GS. Prediction of type 1 diabetes in first degree relatives using a combination of insulin GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-33.
52) American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2001;24(suppl 1) S77-S-79.
53) Javanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-1427.
54) Buchbinder A, Miodovnik M, McElvy S, Rosenn B, Kranias G et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000;183:1162-5.
55) Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Tox 2002;21(3):181-9.
56) Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabets mellitus. Am J Obstet Gynecol 2000;182:1283-91.
57) Nachum Z, Ben-Schlomo I, Weiner E, Salev E. Twice dialy versus four times daily insulin dose regimens for diabetes in pregnancy: randomized controlled trial. BMJ 1999;319:1223-7.
58) Rosenn B, Miodovnik M, Holcberg G et al. Hypoglycemia: the pirce of intensive therapy in insulin dependent diabetes mellitus pregnancies. Obste Gynecol 1995;85:417-22.
59) Rosenn B, Miodovnik M, Khoury J et al. Counterregulatory responses to hypoglycemia in pregnant women witn insulin-dependent diabetes mellitus. Obstet Gynecol 1996;87:568-74.
60) Bjorklund A, Adamson U, Andreasson K et al. Hormonal counterregulation and subjective symptoms during induced hypoglycemia in insulin-dependent diabetes mellitus patients during and after pregnancy. Acta Obstet Gynecol Scand 1998;77:625-35.
61) Kenshole A, Ray J, Keely E. Type 1 and Type 2 Diabetes. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000, pp 253-272.
62) Ryan EA. Pregnancy in diabetes. Med Clin No Amer 1998;82(4):823-45.
63) Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
64) Leveno KJ. Overt diabetes complicating pregnancy. Williams Obstet Supp;Dec 1996/Jan 1997;22:1-14.
65) Buchanan TA, Kjos SI, Montoro MN et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17(4);275-83.
66) Galan, HL, Hobbins, JC. Antepartum fetal surveillance. In Lee RV, Rosene-Montella K, Barbour L, Garner PR, Keely E (ed). Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000:87-103.
67) Chauhan SP, Perry Jr KG. Management of diabetic ketoacidosis in the obstetric patient. Obstet Gynecol Clin No America 1995;22(1):143-55.
68) Cullen MT, Reece EA, Homko CJ et al. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Pernat 1996;13(7):449-51.
69) Rodgers BD, Rodgers DE. Clinical variables associated with diabetic ketoacidosis during pregnancy. J Reprod Med 1991;36(11):797-99.
70) Biesenbach G, Zazgornik J. Incidence of transient nephrotic syndrome during pregnany in diabetic women with and without pre-existing microalbuminuria. BMJ 1989;299366-7.
71) Reece EA, Winn HN, Haylsett JP, Coulehan J, Wan M, Hobbins JC. Does pregnancy alter the rate of progression of diabetic nephropathy? Am J Pernatol 1990;7(2):193-7.
72) Kitzmiller JL, Gavin LA, Gin GD et al. Preconception care of diabetes--glycemic control prevents congenital anomalies. JAMA 1991;265:731-6.
73) Beisenbach G, Grafinger P, Zazgornik J, Helmut, Stoger. Perinatal complications and three-year follow up of infants of diabetic mothers with diabetic nephropathy stage IV. Renal Failure 2000;22(5):573-80.
74) Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24(10):1739-44.
75) Leguzamon G, Reece EA. Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes, and hypertension. J Mat-Fet Med 2000;9(1):70-78.
76) Bar J, Ben-Rafael Z, Padoa A, Orvieto R, Boner G, Hod M. Prediction of pregnancy outcome in subgroups of women with renal disease. Clinical Nephrol 2000;53(6);437-44.
77) Diabetes Control and Compliations Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabets Care 2000;23:1084-91.
78) Axel-Siegel R, Hod M, Fink-Cohen S et al. Diabetic retinopathy during pregnancy. Opthalmol 1996; 103:1815-19.
79) Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L et al. Metabolic control and progression of retinopathy; the diabetes in early pregnancy study. Diabetes Care 1995;18(5);631-7.
80) Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand 2000;79(5):367-70.
81) ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Gestational Diabetes no. 30. Washington :American College of Obstetricians and Gynecologists, 2001.
82) Brody SC, Harris R, Lohr K. Screening for gestational diabetes: A summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101(2):380-92.
83) Metzger BE, Coustan DR, The Organizing Committee. Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 21:B-161-167, 1998.
84) Coustan DR. Making the Diagnosis of Gestational Diabetes Mellitus. Clin Obstet Gynecol 2000;43(1):99-105.
85) Naylor CD, Sermer M, Chen E , Farine D for the Toronto Trihospital Gestational Diabetes Project Investigators. Selective screening for gestational diabetes. N Engl J Med 337:1591-1596, 1997.
86) Danilenki-Dixon DR, Van Winter JT, Nelson RL, Ogburn PL. Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 1999;181:798-802.
87) Zumkeller W. The role of growth hormone and insulin-like growth factors for placental growth and development. Placenta 2000, 21:451-67.
88) Yamada H, Kato EH, Tsuruga R, Ebina Y, Kobashi G, Sagawa T, Makita Z, Koike T, Fujimoto S. Insulin response patterns contribute to different perinatal risks in gestational diabetes. Gynecol Obstet Invest 2001;51:103-9.
89) Shao J, Catalano PM, Yamashita H, Ruyter I, Smith S, Youngren J, Friedman JE. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes (GDM). Diabetes 2000;610:603-10.
90) Greenberg LT, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1993;86:97-101.
91) Kaufmann RC, Schleyhahn FT, Huffman DG, Amankwah KS. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Ob Gyn 1995;172:621-5.
92) Major CA, deVeciana M, Weeks J, Morgan MA. Recurrence of gestational diabetes: who is at risk? Am J Obstet Gynecol 1998;179:1038-42.
93) Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Danish Med Bull 1998;45:495-508.
94) Kjos SL, Peters RJ, Xiang A, Henry OA, Montoro M, Buchanan T. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 44:586-591, 1995.
95) Kjos SL. Postpartum care of the woman with diabetes. Clinical Obstet Gynecol 43:75-90, 2000.
96) Uvena-Celebrezze J, Catalano P. The Infant of the woman with gestational diabetes mellitus. Clinical Ob Gyn 2000;43(1):127-139.
97) Rey E, Attie C. Bonin A. The effect of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999;181:202-6.
98) Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metabol 1999:84:695-701.
99) Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993;269:609-15.
100) Weiss AM, Scholz HS, Haas JH, Tamussino KF. Effect of fetal hyperinsulinemia on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 20001:184:470-5.
101) Langer O. Management of gestational diabetes. Clinical Obstet Gynecol 43:106-115, 2000.
102) Conway DL. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998;178:922-5.
103) Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol 169:611-5, 1993.
104) Lindsay RS, Hanson RL, Bennett PH. Secular trends in birth weight, BMI, and diabetes in the offspring of diabetic mothers. Diabetes Care 2000;23:1249-54.
105) Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993;16:310-4.
106) Silverman BL, Metzger BE. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Diabetes Care 18:611-617, 1995.
107) Javanovic L. Role of diet and insulin treatment of diabetes in pregnancy. Clinical Obstet Gynecol 2000;43(1):46-55.
108) Carpenter MW. The role of exercise in pregnant women with diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):56-64.
109) Gold AE, Reilly C, Walker JD. Transient improvement in glycemic control. Diabetes Care 1998;21(3):374-8.
110) Gerstein HC. Incidence of postpartum thyroid dysfunctionin patients with type 1 diabetes mellitus. Ann Int Med 1993;118:419-23.
111) Barbour LA. Thyroid disease in pregnancy. In McDermott M (ed):, Endocrine Secrets, 3rd ed, Philadelphia, Hanley & Belfus, 2001:308-16.
112) Diabetes Prevention Program Research Gourp. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
113) Conway DL, Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999;191:610-4.
114) Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacolgical treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51(9):2796-803.
115) Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J Nutrition 2001;131(3):874S-80S.
116) Sowers M, Crutchfield M, Jannausch M, Updike S, Corton G. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 1991;77:841-5.
117) Stamm CA, Barbour, LA, McGregor JA. Effective birth control for women with medical disorders. In Lee, RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed). Medical care of the pregnant patient. Philadelphia, American College of Physicians 2000:19-33.
118) Skouby SO, Molsted-Pedersoen L, Huhl C, Bennet P. Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progesterone profiles. Fertil Steril 1986;46:858-64.
119) Rimm EB, Manson JE, Stampfer MJ et al. Oral contraceptive use and the risk of type 2 (non-insulin dependent) diabetes in a large prospective study of women. Diabetologia 1992;35:967-72.